Sheerin N S, Sacks S H
Department of Nephrology and Transplantation, Guy's Hospital Medical and Dental School, King's College, London.
Nephrologie. 1999;20(7):377-82.
The deposition of complement components is a feature of many immune mediated human glomerular diseases. Experimental models provide evidence that complement activation within the glomerulus has a pathogenic role in immune complex and antibody mediated glomerulonephritis. It was thought that the complement components deposited within the kidney were derived from the systemic circulating pool. However, recent work has shown that the kidney is able to produce many of the components of the complement cascade. In vitro work has shown that cells of glomerular and tubular origin can produce complement, as can inflammatory cells present within the kidney during inflammation. Analysis of human biopsy material has shown that expression of complement genes is increased during inflammatory renal disease implicating local complement synthesis as a potential source of complement components. At present no direct evidence for a pathogenic role of local complement synthesis exists. In this review we consider the current experimental evidence which suggests that local production of complement may be contributing to renal injury in a variety of diseases.
补体成分的沉积是许多免疫介导的人类肾小球疾病的一个特征。实验模型提供了证据表明肾小球内的补体激活在免疫复合物和抗体介导的肾小球肾炎中具有致病作用。过去认为沉积在肾脏内的补体成分来源于全身循环池。然而,最近的研究表明肾脏能够产生补体级联反应的许多成分。体外研究表明,肾小球和肾小管来源的细胞能够产生补体,炎症期间肾脏内存在的炎症细胞也能产生补体。对人类活检材料的分析表明,在炎症性肾脏疾病期间补体基因的表达增加,这意味着局部补体合成是补体成分的一个潜在来源。目前尚无直接证据表明局部补体合成具有致病作用。在这篇综述中,我们考虑了当前的实验证据,这些证据表明补体的局部产生可能在多种疾病中导致肾损伤。